In conclusion, this study identifies the miR-135b–BMAL1–YY1 loop as a determinant of pancreatic circadian homoeostasis, and we propose that targeting this signalling pathway may be useful for PC management. The gene discussed is YY1; the disease is pachyonychia congenita.